Miller-The ASAM Principles of Addiction Medicine, 7e

Preface

Welcome to the seventh edition of The ASAM Principles of Addiction Medicine . Our goal, as with previous editions of Principles, is to provide a reference text that reflects the state of the art in the science and practice of addiction medicine. This goal is supported through the textbook’s link to the American Society of Addiction Medicine (ASAM), the world’s largest addiction medicine professional association, and through the involvement of the world’s leading researchers and experts in our field. This edition of Principles is being released after the COVID-19 Federal Public Health Emergency officially ended, the removal of DATA Waiver requirements and changed edu cational requirements, the extended relaxation of telehealth policies, and the relaxation of rules for take-home opioid use disorder treatment. Clinicians face challenging and ever changing legal and social landscapes that shape addiction medicine. The material in this book offers scientific research and evolving best practices to better equip clinicians and poli cymakers to prevent, recognize, and treat addiction-related disorders more efficiently. The text is organized pyramidally under senior editor, associate editors, lead section editors, section editors, and authors. To accommodate the expansion of the seventh edi tion with 11 new chapters and 7 sidebars, and to replace the departure of David Fiellin, MD, and the passing of Rich Saitz, MD, four new associate editors have joined the editorial team: Sarah E. Wakeman, MD, Jeanette M. Tetrault, MD, Sharon Levy, MD, and Andy Saxon, MD. Dr. Wakeman, provides her strength in internal medicine and addiction medicine, with a focus on the integration of substance use disorder care into general medical settings. Dr. Wakeman was the lead editor for ASAM’s Pocket Addiction Medicine. Dr. Tetrault, provides her strength in internal medicine, with a focus on care of patients with addiction and the medical conditions associated with substance use, in particular HIV and hepatitis C. She returns to the textbook after previous ser vice as a section editor. Dr. Levy, provides her strength in pediatrics, with a focus on prevention, screening, evaluation, and treatment of ado lescents and young adults with substance use disorders, and the integration of substance use treatment into primary care pediatrics. Dr. Saxon, provides his strength in addiction psychiatry, with a focus on substance use disorder treatment and educa tion. He returns to the textbook after previous service as a sec tion editor. Dr. Rosenthal, returns as associate editor from the sixth edition and provides his strengths in addiction psychiatry and co-occurring psychiatric disorders, behavioral and 12-step ap proaches, technology-associated disorders, and collaborative team–based care for addiction-related disorders.

Both Richard Saitz, MD, and David Fiellin, MD, who served as associate editors for the fourth, fifth, and sixth editions, provided cornerstones to our links to patient- oriented research, screening and brief intervention, and the management of opioid use disorders, while sharing their wide ranging expertise in internal medicine. Shannon C. Miller, MD, returns from the fourth and fifth editions, where he served as an associate editor. He moved into the Senior Editor role for the sixth edition and has returned to lead this seventh edition of Principles. He provides strengths in psychiatry and neuroscience, military and veteran medi cal care, and his editorial strength as a founding coeditor of ASAM’s peer-reviewed medical journal, Journal of Addiction Medicine . The editors have updated, deleted, added, and reorga nized chapters to provide coherent and compete information, including updates to all chapters and substantial revisions to most. Also, importantly, this edition expanded the frontiers of nonstigmatizing terminology by incorporating recently evolved terminology into all chapters. As well, most authors have provided a unique focus on how the topics of race, diver sity, equity, inclusion, and justice relate to their chapter con tents, especially in chapters dealing with the topics of genetics, epidemiology, assessment, and treatment. Work continued to ensure usage of DSM-5-TR language throughout its chapters, while attempting to preserve linkages to previous DSM edi tions. To maintain Principles as current and relevant to the medical community as our field rapidly expands in breadth and depth, a substantial number of new chapters have been added that are not traditionally covered in addiction related publications. Frank Vocci, PhD, leads Section 1, Basic Science and Core Concepts. The opening chapter, Substance Use Disorders: The Neurobiology of Motivation Gone Awry, is written by Nora D. Volkow, MD, and George F. Koob, PhD, directors of the Na tional Institute on Drug Abuse (NIDA) and the National Insti tute on Alcohol Abuse and Alcoholism (NIAAA), respectively. In addition to orienting the reader to basic principles in neu robiology and epidemiology of addiction, important chapter updates have been added on recommended use of terminology in the field of addiction medicine (Chapter 2), understanding research in addiction-related clinical trials (Chapter 4), and the addiction medicine physician as a change agent toward public health (Chapter 5). Three new chapters explore the important influence and impact industry has on tobacco, alcohol, and cannabis use disorders (Chapters 7, 8, and 9). As well, a novel chapter on the increasingly relevant intersection of addiction medicine and climate change is provided. Thomas R. Kosten, MD, along with David A. Gorelick, MD, and Daryl Shorter, MD, lead Section 2, Pharmacology. This team has worked to better elucidate the clinical relevance

Copyright © 2024 Wolters Kluwer, Inc. Unauthorized reproduction of the content is prohibited.

xxiii